This is a preview of subscription content, log in via an institution to check access.
Reference
Decision Resources. High Cost of Biologics and Novel Oral Agents to Treat Immune Diseases Limits Patient Access. Media Release : 10 Dec 2013. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
High cost limits access to RA, psoriasis treatments. PharmacoEcon Outcomes News 694, 8 (2014). https://doi.org/10.1007/s40274-014-0975-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-0975-z